Aripiprazole
Product Images NDC 17856-0680

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 17856-0680). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corps, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 3 (Aripiprazole 3figure)

FDA Label Image

Figure 2 (Aripiprazole Figure2)

FDA Label Image

Figure 4 (Aripiprazole Figure4)

Figure 4 (Aripiprazole Figure4)
This appears to be an output of statistical analysis of a clinical trial investigating the effects of Aripiprazole on various populations segregated based on different criteria such as age, gender, hepatic impairment, and renal impairment. The results of the analysis are presented in the terms of fold change and the area under the curve (AUC) showing the concentration of Aripiprazole over time. The significance of the results is not discernible from the given text.*
FDA Label Image

Figure 5 (Aripiprazole Figure5)

FDA Label Image

Figure 6 (Aripiprazole Figure6)

Figure 6 (Aripiprazole Figure6)
This appears to be a graph or a table with information related to medication and relapse proportion. Unfortunately, there is insufficient data to make a useful description of the graph.*
FDA Label Image

Figure 7 (Aripiprazole Figure7)

FDA Label Image

Structure (Aripiprazole Str)

FDA Label Image

Trigen Laboratories Llc (Aripiprazole Trigen)

FDA Label Image

Label Image (Lbl178560680)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.